296
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of machine learning applications using real-world EHR data for predicting diabetes-related long-term complications

ORCID Icon, , , , &
Pages 141-151 | Received 01 Jul 2021, Accepted 06 Sep 2021, Published online: 21 Sep 2021
 

ABSTRACT

The biggest concern about diabetes-related complications is that they are unrecognised in the early stages but can be immutable and devastating with time. Identifying the population at high risk of developing such complications can help intervene in preventative care at an early stage. This study aims to present a data-driven approach to predict the patients at higher risk for diabetes-related complications using real-world data. We used comorbid diagnostic features from the electronic health records called “Cerner Health Facts EMR Data” to build machine learning-based prediction models for three diabetes-related long-term complications: (a) eye diseases, (b) kidney diseases, and (c) neuropathy. Our developed pipeline was able to generate highly accurate models for predictions. We deduced from the F1-scores that applying the class balancing techniques improved the overall performance of the models, and SVM with oversampling technique was the most consistent classifier for all three cohorts.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.